Elocta/reITIrate

Haemophilia A
Phase 4

A Non controlled,  Open-Label, Multicenter, Exploratory Phase 2 Study of Efficacy of rFVIIIFC for ITI in severe hemophilia A patients with inhibitors who have failed  previous ITI  therapies

ClinicalTrials.gov Identifier: NCT03103542